Amman, August 6 (Petra) – A Jordanian-Danish health seminar organized by the Jordan Food and Drug Administration (JFDA), in cooperation with the Danish Embassy, opened Wednesday with experts and speakers from Jordan, Denmark, and Egypt.

The seminar aimed to promote the exchange of expertise and review health care practices and experiences.

In a press statement Thursday, JFDA Director-General Rana Obeidat stressed the need for a clear plan to maximize the benefits of health technology assessment systems, particularly the Jordanian Patient Support Program.

Obeidat underscored the importance of exchanging international and regional expertise in health technology assessment to improve practices and support knowledge-based health decisions.

The seminar was moderated by Danish Embassy Head of Economic Diplomacy and Trade Nesreen Obeid and featured presentations, interactive discussions, and question-and-answer sessions.

Head of the Pharmacoeconomics Division Al Hanouf Al-Rudaini presented the JFDA’s role in medicine pricing, which is based on approved pricing criteria and economic studies.

The seminar also addressed health technology assessment as a tool for supporting evidence-based decision-making, improving spending efficiency, strengthening pharmaceutical and treatment decisions, and facilitating access to modern therapies in line with international health standards.

//Petra// AO